Neko Health is awaiting regulatory approval to open its first U.S. clinic in New York, bringing the medical scanning startup founded by Spotify’s Daniel Ek and Hjalmar Nilsonne into the American longevity market. The company raised $250 million in Series B funding at a $1.8 billion valuation earlier this year as demand for preventive health scans grows among consumers. Its New York scan is expected to cost about $500, according to sources cited by Sifted, keeping Neko below incumbent full-body imaging companies such as Prenuvo and Ezra.
Neko has carried out five times more scans each year since entering the United Kingdom in September 2024. Its initial London clinic appointments sold out within 10 minutes, generating a waitlist of approximately 100,000 customers. The company has since opened additional clinics across London, Birmingham, and Manchester to meet demand.
Neko provides an hour-long, AI-powered health check-up that includes skin mapping, blood testing, ECG screening, grip strength testing, and a doctor consultation. At €300 in Europe, the scan costs roughly one-tenth of competing private health imaging services. To sustain lower pricing, the company is investing capital into AI models that can automate more parts of the scanning process.
The planned U.S. expansion coincides with a software transition. Neko is preparing to launch a mobile app that integrates continuous telemetry from consumer wearables like Oura and Whoop. The app would allow customers to supplement annual scans with year-round metabolic and biometric data.
Founder Hjalmar Nilsonne stated, "Right now, I think we’re in the ‘affordable luxury’ category, where we provide something of very high quality, but at a price that you don’t have to be a finance mogul to afford." Neko ultimately plans to use its accumulated patient data to pursue commercial partnerships with insurers, employers, and traditional health systems.
